As shown in Fig. 4c, a number of glycolysis genes were consistently upregulated in primary AML cells representing different risk categories, and in particular an upregulation of SLC2A3, PKM, PDK1, PDK2 and SLC16A3 was noted. The gene discussed is PKM; the disease is acute myeloid leukemia.